These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum. Liu J, Shimizu K, Konishi F, Kumamoto S, Kondo R. Bioorg Med Chem; 2007 Jul 15; 15(14):4966-72. PubMed ID: 17499997 [Abstract] [Full Text] [Related]
3. Anti-androgen effects of extracts and compounds from Ganoderma lucidum. Liu J, Tamura S, Kurashiki K, Shimizu K, Noda K, Konishi F, Kumamoto S, Kondo R. Chem Biodivers; 2009 Feb 15; 6(2):231-43. PubMed ID: 19235153 [Abstract] [Full Text] [Related]
4. Regulation of osteoclastogenesis by ganoderic acid DM isolated from Ganoderma lucidum. Miyamoto I, Liu J, Shimizu K, Sato M, Kukita A, Kukita T, Kondo R. Eur J Pharmacol; 2009 Jan 05; 602(1):1-7. PubMed ID: 19026632 [Abstract] [Full Text] [Related]
5. Ganoderic acids from Ganoderma lucidum: inhibitory activity of osteoclastic differentiation and structural criteria. Liu J, Shiono J, Shimizu K, Kondo R. Planta Med; 2010 Feb 05; 76(2):137-9. PubMed ID: 19670160 [Abstract] [Full Text] [Related]
7. Structure-activity relationship for inhibition of 5alpha-reductase by triterpenoids isolated from Ganoderma lucidum. Liu J, Kurashiki K, Shimizu K, Kondo R. Bioorg Med Chem; 2006 Dec 15; 14(24):8654-60. PubMed ID: 16962782 [Abstract] [Full Text] [Related]
11. Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of Ganoderma lucidum. Fatmawati S, Shimizu K, Kondo R. Fitoterapia; 2010 Dec 15; 81(8):1033-6. PubMed ID: 20603199 [Abstract] [Full Text] [Related]
12. Anti-androgenic activity of fatty acids. Liu J, Shimizu K, Kondo R. Chem Biodivers; 2009 Apr 15; 6(4):503-12. PubMed ID: 19353546 [Abstract] [Full Text] [Related]
13. Cytotoxic triterpenoids from Ganoderma lucidum. Cheng CR, Yue QX, Wu ZY, Song XY, Tao SJ, Wu XH, Xu PP, Liu X, Guan SH, Guo DA. Phytochemistry; 2010 Sep 15; 71(13):1579-85. PubMed ID: 20615519 [Abstract] [Full Text] [Related]
14. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Min BS, Gao JJ, Nakamura N, Hattori M. Chem Pharm Bull (Tokyo); 2000 Jul 15; 48(7):1026-33. PubMed ID: 10923835 [Abstract] [Full Text] [Related]
18. Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y. Liang C, Tian D, Liu Y, Li H, Zhu J, Li M, Xin M, Xia J. Eur J Med Chem; 2019 Jul 15; 174():130-141. PubMed ID: 31035236 [Abstract] [Full Text] [Related]
19. Extraction optimisation and isolation of triterpenoids from Ganoderma lucidum and their effect on human carcinoma cell growth. Ruan W, Lim AH, Huang LG, Popovich DG. Nat Prod Res; 2014 Jul 15; 28(24):2264-72. PubMed ID: 25032738 [Abstract] [Full Text] [Related]
20. Steroids and triterpenes from the fruit bodies of Ganoderma lucidum and their anti-complement activity. Seo HW, Hung TM, Na M, Jung HJ, Kim JC, Choi JS, Kim JH, Lee HK, Lee I, Bae K, Hattori M, Min BS. Arch Pharm Res; 2009 Nov 15; 32(11):1573-9. PubMed ID: 20091270 [Abstract] [Full Text] [Related] Page: [Next] [New Search]